Pulmonary arterial hypertension.

Farber HW; Loscalzo J

doi:10.1056/nejmra035488

Pulmonary arterial hypertension.

Farber HW ¹,

Loscalzo J

Affiliations

1. Evans Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Authors
Farber HW¹
(1 author)

ORCIDs linked to this article

Farber HW | 0000-0002-0297-7902

The New England Journal of Medicine, 01 Oct 2004, 351(16):1655-1665
https://doi.org/10.1056/nejmra035488 PMID: 15483284

Review

A comment on this article appears in "Pulmonary hypertension." N Engl J Med. 2005 Jan 27;352(4):418-9; author reply 418-9. A comment on this article appears in "Pulmonary hypertension." N Engl J Med. 2005 Jan 27;352(4):418-9; author reply 418-9.

Abstract

No abstract provided.

Full text links

Read article at publisher's site: https://doi.org/10.1056/nejmra035488

References

Articles referenced by this article (83)

Medical therapy of pulmonary hypertension. An overview of treatment and goals.
Barst RJ
Clin Chest Med, (3):509-15, ix 2001
MED: 11590844
Clinical classification of pulmonary hypertension.
Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A
J Am Coll Cardiol, (12 Suppl S):5S-12S 2004
MED: 15194173
Primary pulmonary hypertension.
Gaine SP, Rubin LJ
Lancet, (9129):719-725 1998
MED: 9729004
Primary pulmonary hypertension.
Rubin LJ
N Engl J Med, (2):111-117 1997
MED: 8988890
Prostanoids for pulmonary arterial hypertension.
Galie N, Manes A, Branzi A
Am J Respir Med, (2):123-137 2003
MED: 14720012
Drug therapy for pulmonary arterial hypertension: what's on the menu today?
Mehta S
Chest, (6):2045-2049 2003
MED: 14665473
Moderation of hypoxic vasoconstriction by infused arachidonic acid: role of PGI2.
Gerber JG, Voelkel N, Nies AS, McMurtry IF, Reeves JT
J Appl Physiol Respir Environ Exerc Physiol, (1):107-112 1980
MED: 6995413
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE
N Engl J Med, (2):70-75 1992
MED: 1603138
Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.
Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, Badesch D, Voelkel NF
Am J Respir Crit Care Med, (6):1925-1932 1999
MED: 10351941
Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells.
Hassoun PM, Thappa V, Landman MJ, Fanburg BL
Proc Soc Exp Biol Med, (2):165-170 1992
MED: 1741408

Show 10 more references (10 of 83)

Citations & impact

Impact metrics

710

Citations

Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/679343

Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/679343

Smart citations by scite.ai
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1056/nejmra035488

Supporting

Mentioning

Contrasting

836

Article citations

Impact of Age and of the Patent Ductus Arteriosus on Pulmonary Hemodynamics in Children with Complete Atrioventricular Septal Defect.
Rocha LO, Miyague NI, Solarewicz LA, Fernandes-Silva MM
Pediatr Cardiol, 02 Sep 2024
Cited by: 0 articles | PMID: 39223337
Phosphodiesterase 9A inhibition improves aging-related increase in pulmonary vascular resistance in mice.
Buncha V, Fopiano KA, Lang L, Ilatovskaya DV, Verin A, Bagi Z
Geroscience, 46(5):5191-5202, 09 Jul 2024
Cited by: 0 articles | PMID: 38980632 | PMCID: PMC11335997
Free full text in Europe PMC
NOTCH3 and Pulmonary Arterial Hypertension.
Winicki NM, Puerta C, Besse CE, Zhang Y, Thistlethwaite PA
Int J Mol Sci, 25(11):6248, 06 Jun 2024
Cited by: 0 articles | PMID: 38892440 | PMCID: PMC11172835
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
New Kid on the Block: GLI1+ Cells and Pulmonary Arterioles Neomuscularization.
Al Ghouleh I, Pulgarin Rocha A, Goncharova EA
Circ Res, 134(11):1402-1404, 23 May 2024
Cited by: 0 articles | PMID: 38781304
Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics.
Ba H, Guo Y, Jiang Y, Li Y, Dai X, Liu Y, Li X
Respir Res, 25(1):221, 28 May 2024
Cited by: 0 articles | PMID: 38807129 | PMCID: PMC11131231
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

Go to all (710) article citations

Search life-sciences literature (45,103,589 articles, preprints and more)

Pulmonary arterial hypertension.

Affiliations

Authors

ORCIDs linked to this article

Abstract

Full text links

References

Medical therapy of pulmonary hypertension. An overview of treatment and goals.

Clinical classification of pulmonary hypertension.

Primary pulmonary hypertension.

Primary pulmonary hypertension.

Prostanoids for pulmonary arterial hypertension.

Drug therapy for pulmonary arterial hypertension: what's on the menu today?

Moderation of hypoxic vasoconstriction by infused arachidonic acid: role of PGI2.

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.

Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.

Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells.

Citations & impact

Impact metrics

Citations of article over time

Alternative metrics

Smart citations by scite.ai
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1056/nejmra035488

Article citations

Impact of Age and of the Patent Ductus Arteriosus on Pulmonary Hemodynamics in Children with Complete Atrioventricular Septal Defect.

Phosphodiesterase 9A inhibition improves aging-related increase in pulmonary vascular resistance in mice.

NOTCH3 and Pulmonary Arterial Hypertension.

New Kid on the Block: GLI1+ Cells and Pulmonary Arterioles Neomuscularization.

Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics.

Similar Articles

Primary pulmonary hypertension: molecular basis and potential for therapy.

Current insights on the pathogenesis of pulmonary arterial hypertension.

Cellular and molecular pathobiology of pulmonary arterial hypertension.

Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.

Partnerships & funding

Similar Articles

Primary pulmonary hypertension: molecular basis and potential for therapy.

Current insights on the pathogenesis of pulmonary arterial hypertension.
Semin Respir Crit Care Med, 26(4):355-364, 01 Aug 2005

Cellular and molecular pathobiology of pulmonary arterial hypertension.
J Am Coll Cardiol, 43(12 suppl s):13S-24S, 01 Jun 2004

Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
Int J Mol Med, 21(1):99-107, 01 Jan 2008

Search life-sciences literature (45,103,589 articles, preprints and more)

Pulmonary arterial hypertension.

Author information

Affiliations

Authors

ORCIDs linked to this article

Abstract

Full text links

References

Citations & impact

Impact metrics

Citations of article over time

Alternative metrics

Article citations

Similar Articles

Partnerships & funding